logo
  

Daimler Supervisory Board To Propose Bernd Pischetsrieder As Chairman - Quick Facts

Daimler AG (DDAIF.PK) said its Supervisory Board will propose to the 2021 Annual Shareholders' Meeting the election of three new persons. The candidates are: Elizabeth Centoni, Ben van Beurden, and Martin Brudermüller. The Supervisory Board also agreed that in its meeting to be held after the Annual Shareholders' Meeting to propose to the newly constituted Supervisory Board that Bernd Pischetsrieder be elected as its Chairman. Bernd Pischetsrieder has been a member of the Supervisory Board of Daimler AG since 2014.

Ben van Beurden is CEO of Royal Dutch Shell plc. Martin Brudermüller has been Chairman of the Board of Executive Directors of BASF SE.

At the end of the Shareholders' Meeting on March 31, 2021, the term of office of the Chairman, Manfred Bischoff, will expire and he will step down from the Supervisory Board. Petraea Heynike and Jürgen Hambrecht will also step down from the Supervisory Board.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Lincoln Park, New Jersey -based ConSup North America Inc. is recalling around 85,984 pounds of ready-to-eat or RTE sliced prosciutto ham product produced in Germany without the benefit of equivalent inspection, the U.S. Department of Agriculture's Food Safety and Inspection Service or FSIS announced. French drug major Sanofi reported Thursday weak profit in its first quarter, despite higher net sales. The company also maintained its fiscal 2024 outlook. Sanofi shares were gaining around 4 percent in Paris trading as well as in pre-market activity on the Nasdaq. While reporting financial results for the first quarter on Wednesday, medical devices company Boston Scientific Corp. (BSX) raised its adjusted earnings and net sales growth guidance for the full-year 2024. For fiscal 2024, the company now projects earnings in a range of $1.43 to $1.48 per share and...

This week, we feature Nigeria’s combat with meningitis, Hostile takeover bid for Vanda Pharma, US opioid crisis, Sammy’s Milk’s safety concerns, and X4’s Mavorixafor’s fast-track status.

View More Videos
Follow RTT